Park Medi World is set to benefit from India’s hospital bed shortage and growth in Tier II markets. Nuvama initiated coverage with a ‘Buy’ rating and a target price of ₹280, projecting a 37% upside. The company aims to expand bed capacity significantly by FY28.
